Continuous Renal Replacement Therapy Market to Reach Approximately Over US$ 1000 Mn by 2025 - TMR

Wednesday, April 11, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

ALBANY, New York, April 11, 2018 /PRNewswire/ --

The global continuous renal replacement therapy market was valued

at nearly US$ 700.0 Mn in 2016 and is anticipated to register compound annual growth rate (CAGR) of over 6.5% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled "Continuous
Renal Replacement Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017-2025." The report suggests that increase in incidence of acute kidney injury is anticipated to increase the demand for continuous renal replacement therapy during the forecast period. As key players introduce their new CRRT devices in developed regions such as Western Europe and North America, these regions are likely to account for dominant share of the global continuous renal replacement therapy market. Rising burden of acute renal failure in emerging markets such as China and India is likely to boost growth of the Asia Pacific continuous renal replacement therapy market at a CAGR of over 9% from 2017 to 2025.

     (Logo: )

Get PDF Brochure for Research Insights at

Stringent Rules & Regulations to Restrain Global Market Expansion 

In continuous renal replacement therapy, the fluid status of the patient is controlled with the help of an electrolyte solution, the patient's blood is cleaned, uremic toxins are removed, acid-base abnormalities and electrolyte are corrected, and extracorporeal blood circuit is required. Increasing prevalence of acute kidney injury is expected to drive the expansion of the market during the forecast period. The sudden failure of kidneys due to various indications leads to acute kidney injury. All over the world, every year approximately 3 million end-stage renal disease patients, and 470,000 end-stage renal disease patients in the U.S. are dependent on life-sustaining dialysis treatment. In the next 10 years, the number of patients is anticipated to double. According to U.S. data, 5% to 20% experience acute kidney injury during their course of illness in the ICU, and as acute kidney injury develops, there is a huge negative impact on outcomes of any illness.

The global continuous renal replacement therapy market has been classified based on mode, product, therapy, end-user, and region. Based on mode, the market has been categorized into slow continuous ultrafiltration, continuous veno venous haemo-filtration, continuous veno venous haemo-dialysis, and continuous veno venous haemo-dia-filtration. Among these, continuous veno venous haemo-filtration segment leads the market and is expected to continue its dominance during the forecast period followed by continuous veno venous haemo-dialysis. The high share of the continuous veno venous haemo-filtration segment is attributed due to CVVH being more effective than continuous veno venous haemo-dia-filtration (CVVHDF), and associated with fewer complications. In terms of product, the market has been classified into dialysate and replacement fluids, disposables, and systems. Disposables can further be divided into bloodline sets, haemo-filters, and other disposables. Among the products, disposables segment held the largest market share in 2016 and is anticipated to gain market share during the forecast period. The growth of the segment is attributed to high volume sales of disposables for continuous renal replacement therapy. Among the sub segments, haemo-filters held the maximum market share in 2016 and is projected to dominate the market during the forecast period.

Request a Custom Report at

Most Promising End-user is Hospitals 

Based on therapy, the market has been segmented into renal, non-renal, and combination of both. Among therapies, renal segment held maximum share in 2016 and is anticipated to dominate the market during the forecast period. This large market share is attributed to increasing prevalence of acute kidney injury. However, the combination of both renal and non-renal segment is anticipated to expand at the highest rate owing to increasing geriatric population all over the world.

In terms of end-user, the market has been categorized into hospitals, clinics, and homes. Among end-users, hospitals segment held the largest share in 2016 and is anticipated to lead the market during the forecast period. This is attributed to increasing number of intensive care units all over the world. However, homes segment is projected to expand at the highest CAGR during the forecast period.

Request For Discount On This Report:

Asia Pacific to Offer Huge Incremental Opportunity and Resister High Growth 

Geographically, Europe captured maximum share of the global continuous renal replacement therapy market in 2016. The dominance of the region is because Europe is home to many key players of the global continuous renal replacement therapy market. The market in Asia Pacific is anticipated to expand at the fastest growth rate during the forecast period. Increasing government initiations in the healthcare sector by developing countries of the region are projected to fuel the growth of the market. Initiatives by local governments to attain self-sufficiency in manufacturing medical devices are likely to boost market growth in Middle East & Africa and Latin America.

Key Companies Such as Merck & Co., Inc., and GlaxoSmithKline plc. are Likely to Continue to Lead the Global Continuous Renal Replacement Therapy Market 

Key players operating in the global continuous renal replacement therapy market and profiled in the report include Baxter International, Inc., Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Bellco, Fresenius Medical Care AG & Co. KGaA, NxStage Medical, Inc., Nipro Corporation, NIKKISO CO., LTD., Toray Medical Company Limited, and INFOMED SA. These players adopt inorganic, and organic growth strategies to drive their device offerings, strengthen their reach all over the world, garner market share, and increase their customer base.

Popular Research Reports by TMR: 

  • Renal Cell Carcinoma Market:
  • Kidney Dialysis Equipment Market:

About Us 

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email:


Research Blog:

SOURCE Transparency Market Research

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store